Managing High-Priority Risks and Aligning Compliance with Business Innovation
- London, United Kingdom
Backed by 15+ years of experience providing an interactive, senior-level forum for Chief Compliance Officers and their teams, CBI’s 6th Annual Global Compliance Congress convenes life science companies to share ideas, benchmark and learn about the latest trends and regulations around the world. This fully-packed 2-day forum includes topics such as patient support, competition law, anti-bribery and anti-corruption, digital technologies, data privacy, clinical trials as well as many other issues faced by the industry.
Join Your Colleagues for These 2019 Benefits and Features:
- Engage with industry pioneers at this highly collaborative event and benefit from 5+ hours of dedicated networking opportunities
- Share insights and ideas in peer-to-peer roundtable discussions
- Identify the emerging challenges with data disclosure
initiatives across developed and emerging markets - Learn strategies for balancing standardised compliance training with customised content for international audiences
- Review current ABAC regulations and strategise around risk mitigation for your business
- Examine the risks and legal challenges around pharmaceutical marketing — promotions, advertising and digital platforms
- Assess GDPR best practices in light of recent cases
Previous Attendee Acclaim:
I always benefit from knowing every company faces challenges in the area of financial disclosure and ethics compliance. This conferences allows me to share with
Global Cross-Border Transparency Lead, Novartis
and learn from other company peers.
Very good topics and variety of speakers bringing
Vice President, Compliance Europe, AstraZeneca
different perspectives. It was great to refresh networking, discuss best practices and bring others’ perspectives
back to my organization.
Breakout sessions were excellent. Very interactive.
Corporate Compliance Director, Biogen
Excellent content from the speakers.
6th Annual Global Compliance Congress
Managing High-Priority Risks and Aligning Compliance with Business Innovation
Backed by 15+ years of experience providing an interactive, senior-level forum for Chief Compliance Officers and their teams, CBI’s 6th Annual Global Compliance Congress convenes life science companies to share ideas, benchmark and learn about the latest trends and regulations around the world. This fully-packed 2-day forum includes topics such as patient support, competition law, anti-bribery and anti-corruption, digital technologies, data privacy, clinical trials as well as many other issues faced by the industry.
Join Your Colleagues for These 2019 Benefits and Features:
- Engage with industry pioneers at this highly collaborative event and benefit from 5+ hours of dedicated networking opportunities
- Share insights and ideas in peer-to-peer roundtable discussions
- Identify the emerging challenges with data disclosure
initiatives across developed and emerging markets - Learn strategies for balancing standardised compliance training with customised content for international audiences
- Review current ABAC regulations and strategise around risk mitigation for your business
- Examine the risks and legal challenges around pharmaceutical marketing — promotions, advertising and digital platforms
- Assess GDPR best practices in light of recent cases
Previous Attendee Acclaim:
I always benefit from knowing every company faces challenges in the area of financial disclosure and ethics compliance. This conferences allows me to share with
Global Cross-Border Transparency Lead, Novartis
and learn from other company peers.
Very good topics and variety of speakers bringing
Vice President, Compliance Europe, AstraZeneca
different perspectives. It was great to refresh networking, discuss best practices and bring others’ perspectives
back to my organization.
Breakout sessions were excellent. Very interactive.
Corporate Compliance Director, Biogen
Excellent content from the speakers.
